Tickers

1. Composite Trajectory Verdict

All three financial statements carry roughly equal weight for this engineering and construction company: the income statement reflects project margin realization and the impact of discrete items (Santos judgment, NuScale fair-value swings), the cash flow statement shows the heavy working-capital intensity of lump-sum and reimbursable EPC contracts, and the balance sheet captures the liquidity cushion needed for performance guarantees and joint-venture funding.

Composite Trajectory: Mixed

The annual series (FY2023–FY2025) shows deterioration in core earnings (net earnings excluding equity-method earnings fell from $355 million in FY2024 to –$364 million in FY2025) and operating cash flow (from $828 million to –$387 million), driven by the $643 million Santos revenue reversal and $108 million of infrastructure project cost growth. The quarterly year-to-date series (YTD 2025 vs. YTD 2026) shows improvement: core earnings rose from $71 million to $227 million, operating cash flow improved from –$307 million to –$207 million, and backlog grew from $25.5 billion to $26.9 billion. Cash and marketable securities increased to $3.0 billion at June 30 2026 from $2.2 billion at December 31 2025, funded entirely by NuScale share sales ($1.83 billion YTD 2026), while shareholders’ equity declined to $2.69 billion from $3.24 billion due to $816 million of share repurchases. The trajectory is therefore mixed: annual trends deteriorated sharply in FY2025, but the most recent interim period shows operational improvement offset by continued reliance on asset sales for liquidity.

2. Red Flags

• GAAP net earnings vs. core earnings divergence: FY2024 GAAP net earnings $2,084 million vs. core (excl. equity-method) $355 million; FY2025 GAAP –$62 million vs. core –$364 million; YTD 2025 GAAP $2,206 million vs. core $71 million; YTD 2026 GAAP $289 million vs. core $227 million (10-K 2025, Consolidated Statements of Operations; 10-Q 2026-06-30, Condensed Statements of Operations).
• Negative operating cash flow in two consecutive periods: FY2025 –$387 million (including $642 million Santos payment) and YTD 2026 –$207 million (including $357 million tax payments on NuScale conversion) (10-K 2025, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Consolidated Statements of Cash Flows).
• Share repurchases funded by asset sales while operating cash flow is negative: $754 million repurchased in FY2025 and $816 million in YTD 2026, financed largely by $605 million (FY2025) and $1.83 billion (YTD 2026) of NuScale proceeds (10-K 2025, Financing Activities; 10-Q 2026-06-30, Financing Activities).
• Backlog decline in FY2025: Total backlog fell from $28.5 billion to $25.5 billion as execution pace exceeded new awards (10-K 2025, Backlog table).
• Legacy loss projects: $255 million backlog with $212 million unfunded losses at FY2025; improved to $119 million backlog with $68 million unfunded at Q2 2026 (10-K 2025, Operating Activities; 10-Q 2026-06-30, Operating Activities).
• Kuwait project letters of credit: $347 million at FY2025 and $97 million at Q2 2026 for substantially complete lump-sum projects awaiting unapproved change orders (10-K 2025, Letters of Credit; 10-Q 2026-06-30, Letters of Credit).
• Effective tax rate volatility: 103 % (FY2024), 39 % (FY2025), 24 % (Q2 2025), 17 % (Q2 2026) and 6 % (YTD 2026) including equity-method earnings (10-K 2025, Income tax reconciliation; 10-Q 2026-06-30, Income Taxes).
• NCI distributions spike: $64 million in FY2025 vs. $14 million in FY2024 (10-K 2025, Financing Cash Flow).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual core earnings (net earnings excluding equity-method earnings) swung from $79 million (FY2023) to $355 million (FY2024) to –$364 million (FY2025) (10-K 2025, Net earnings excluding equity method earnings table). GAAP operating profit followed a similar pattern: $147 million (FY2023), $463 million (FY2024), –$378 million (FY2025) (10-K 2025, Consolidated Statements of Operations). The FY2025 decline was driven by the $643 million Santos revenue reversal and $108 million of cost growth on three infrastructure projects (10-K 2025, Segment Operations). In contrast, the year-to-date quarterly comparison shows improvement: core earnings rose from $71 million (YTD 2025) to $227 million (YTD 2026), operating profit from $65 million to $226 million, and pre-tax earnings from $99 million to $262 million (10-Q 2026-06-30, Consolidated Statements of Operations). Segment profit margins improved in Energy Solutions (11.4 % vs. 2.7 % YTD) and Mission Solutions (–2.1 % vs. 2.9 % YTD, though the latter includes a $98 million Q1 2026 court-ruling charge), while Urban Solutions margin declined to 0.8 % from 2.3 % due to a $37 million mining JV cost growth (10-Q 2026-06-30, Segment Operations). Revenue was flat YTD ($7.99 billion vs. $7.96 billion) (10-Q 2026-06-30, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Mixed

Annual operating cash flow dropped from $828 million (FY2024) to –$387 million (FY2025), primarily due to the $642 million Santos payment (10-K 2025, Consolidated Statements of Cash Flows). Year-to-date operating cash flow improved from –$307 million (YTD 2025) to –$207 million (YTD 2026), though both periods were negative and included large tax payments ($83 million and $418 million, respectively) (10-Q 2026-06-30, Consolidated Statements of Cash Flows). Investing cash flow swung from –$333 million (FY2024) to $437 million (FY2025) to $1.78 billion (YTD 2026), driven by NuScale share sales ($605 million in FY2025, $1.83 billion YTD 2026) and the $124 million CFHI sale in 2026 (10-K 2025, Investing Cash Flow; 10-Q 2026-06-30, Investing Cash Flow). Financing cash outflows accelerated: –$116 million (FY2024), –$797 million (FY2025), –$766 million (YTD 2026), dominated by share repurchases ($125 million, $754 million, $816 million) (10-K 2025, Financing Cash Flow; 10-Q 2026-06-30, Financing Cash Flow). Cash and marketable securities ended at $3.0 billion (June 30 2026) vs. $2.2 billion (December 31 2025) and $3.0 billion (December 31 2024) (10-Q 2026-06-30, Condensed Consolidated Balance Sheet; 10-K 2025, Liquidity and Capital Resources).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Total assets declined from $9.14 billion (FY2024) to $8.24 billion (FY2025) to $7.54 billion (Q2 2026), reflecting the NuScale investment liquidation ($1.58 billion at FY2025 to $0 at Q2 2026) and share repurchases (10-K 2025, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). Shareholders’ equity fell from $3.95 billion (FY2024) to $3.24 billion (FY2025) to $2.69 billion (Q2 2026), with retained earnings decreasing from $3.12 billion to $3.06 billion to $2.98 billion and APIC reduced from $1.17 billion to $443 million to $0 (10-K 2025, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). Long-term debt remained stable at ~$1.07 billion across all three dates (10-K 2025, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). Backlog increased from $25.5 billion (FY2025) to $26.9 billion (Q2 2026), with reimbursable backlog rising from 81 % to 85 % (10-K 2025, Backlog table; 10-Q 2026-06-30, Backlog table). Contract assets grew from $1.15 billion to $1.44 billion, while contract liabilities fell from $633 million to $541 million (10-K 2025, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets). The credit facility remained undrawn with $903 million borrowing capacity at Q2 2026 (10-Q 2026-06-30, Liquidity and Capital Resources).

6. Data Gaps

• Full FY2023 balance sheet detail (total equity, debt composition) to complete the three-year annual trend.
• Standalone Q1 2026 quarterly figures (only YTD and Q2 quarters are provided in the 10-Q).
• Segment-level cash flow statements to assess working capital dynamics by segment.
• Detailed breakdown of the “Other” segment assets and earnings after NuScale and Stork divestitures.
• FY2026 full-year guidance or updated backlog conversion assumptions beyond “approximately half of ending 2025 backlog” (10-K 2025, Backlog footnote 3).